What’s happening: A bipartisan group of U.S. representatives is leading a letter to U.S. Health and Human Services (HHS) Secretary Xavier Becerra about efforts by Johnson & Johnson (J&J) to undermine the 340B Drug Discount Program. What else to know: The deadline for signatures is expected to be extended but since the House could go...
This content is restricted to members.
